The Paracrine Effects of Adipocytes on Lipid Metabolism in Doxorubicin-treated Triple Negative Breast Cancer Cells

Overview

Journal Adipocyte

Specialties Cell Biology
Endocrinology
Physiology

Date 2021 Nov 23

PMID 34812105

Citations 4

Authors

Ilze Mentoor

Anna-Mart Engelbrecht

Mari van de Vyver

Paul J Van Jaarsveld

Theo Nell

Affiliations

Soon will be listed here.

Abstract

Adipocytes in the breast tumour microenvironment promotes acquired treatment resistance. We used an in vitro adipocyte-conditioned media approach to investigate the direct paracrine effects of adipocyte secretory factors on MDA-MB-231 breast cancer cells treated with doxorubicin to clarify the underlying treatment resistance mechanisms. Cell-viability assays, and Western blots were performed to determine alterations in apoptotic, proliferation and lipid metabolism protein markers. Free fatty acids (FFA) and inflammatory markers in the collected treatment-conditioned media were also quantified. Adipocyte secretory factors increased the cell-viability of doxorubicin-treated cells (p < 0.0001), which did not correspond to apoptosis or proliferation pathways. Adipocyte secretory factors increased the protein expression of hormone-sensitive lipase (p < 0.05) in doxorubicin-treated cells. Adipocyte secretory factors increased the utilization of leptin (p < 0.05) and MCP-1 (p < 0.01) proteins and possibly inhibited release of linoleic acid by doxorubicin-treated cells (treatment-conditioned media FFA profiles). Adipocyte secretory factors induced doxorubicin treatment resistance, by increasing the utilization of inflammatory mediators and inhibiting the release of FFA by doxorubicin-treated cells. This further promotes inflammation and lipid metabolic reprogramming (lipid storage) in the tumour microenvironment, which breast cancer cells use to evade the toxic effects induced by doxorubicin and confers to acquired treatment resistance.

Citing Articles

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.

Liu Y, Zou Y, Ye Y, Chen Y Cancer Med. 2024; 13(22):e70410.

PMID: 39558881 PMC: 11574469. DOI: 10.1002/cam4.70410.

Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors.

Gherman M, Zanoaga O, Budisan L, Raduly L, Berindan-Neagoe I Vet Sci. 2023; 10(11).

PMID: 37999477 PMC: 10674590. DOI: 10.3390/vetsci10110654.

Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model.

Araujo R, Fabris V, Lamb C, Elia A, Lanari C, Helguero L J Proteome Res. 2023; 23(8):2815-2829.

PMID: 37497607 PMC: 11301694. DOI: 10.1021/acs.jproteome.3c00382.

The pleiotropic roles of adipocyte secretome in remodeling breast cancer.

Zhou X, Zhang J, Lv W, Zhao C, Xia Y, Wu Y J Exp Clin Cancer Res. 2022; 41(1):203.

PMID: 35701840 PMC: 9199207. DOI: 10.1186/s13046-022-02408-z.

References

Liao Z, Tan Z, Zhu P, Tan N . Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy. Cell Immunol. 2018; 343:103729. DOI: 10.1016/j.cellimm.2017.12.003. View

Li N, Sancak Y, Frasor J, Atilla-Gokcumen G . A Protective Role for Triacylglycerols during Apoptosis. Biochemistry. 2017; 57(1):72-80. PMC: 5975242. DOI: 10.1021/acs.biochem.7b00975. View

Mentoor I, Engelbrecht A, Van Jaarsveld P, Nell T . Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment. Front Endocrinol (Lausanne). 2019; 9:758. PMC: 6297254. DOI: 10.3389/fendo.2018.00758. View

Park J, Euhus D, Scherer P . Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev. 2011; 32(4):550-70. PMC: 3369575. DOI: 10.1210/er.2010-0030. View

Dietze E, Chavez T, Seewaldt V . Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology. Am J Pathol. 2017; 188(2):280-290. PMC: 5785535. DOI: 10.1016/j.ajpath.2017.09.018. View

Lee Y, Jung W, Koo J . Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells. Breast Cancer Res Treat. 2015; 153(2):323-35. DOI: 10.1007/s10549-015-3550-9. View

Roberts D, Dive C, Renehan A . Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2009; 61:301-16. DOI: 10.1146/annurev.med.080708.082713. View

Nestal de Moraes G, Vasconcelos F, Delbue D, Mognol G, Sternberg C, Viola J . Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels. Eur J Cell Biol. 2013; 92(8-9):247-56. DOI: 10.1016/j.ejcb.2013.08.001. View

Mehdizadeh A, Bonyadi M, Darabi M, Rahbarghazi R, Montazersaheb S, Velaei K . Common chemotherapeutic agents modulate fatty acid distribution in human hepatocellular carcinoma and colorectal cancer cells. Bioimpacts. 2017; 7(1):31-39. PMC: 5439387. DOI: 10.15171/bi.2017.05. View

10.

Manni A, Richie J, Schetter S, Calcagnotto A, Trushin N, Aliaga C . Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women. Eur J Clin Nutr. 2017; 71(6):762-765. DOI: 10.1038/ejcn.2016.273. View

11.

Yang D, Li Y, Xing L, Tan Y, Sun J, Zeng B . Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression. Cell Commun Signal. 2018; 16(1):32. PMC: 6006729. DOI: 10.1186/s12964-018-0221-6. View

12.

van de Vyver M, Andrag E, Cockburn I, Ferris W . Thiazolidinedione-induced lipid droplet formation during osteogenic differentiation. J Endocrinol. 2014; 223(2):119-32. DOI: 10.1530/JOE-14-0425. View

13.

Chen H, Ding A, Wang M . Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women. Springerplus. 2016; 5:594. PMC: 4864763. DOI: 10.1186/s40064-016-2200-y. View

14.

Koellensperger E, Bonnert L, Zoernig I, Marme F, Sandmann S, Germann G . The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction. Stem Cell Res Ther. 2017; 8(1):121. PMC: 5445287. DOI: 10.1186/s13287-017-0579-1. View

15.

Lehuede C, Li X, Dauvillier S, Vaysse C, Franchet C, Clement E . Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP). Breast Cancer Res. 2019; 21(1):7. PMC: 6337862. DOI: 10.1186/s13058-018-1088-6. View

16.

Wang L, Tang C, Cao H, Li K, Pang X, Zhong L . Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther. 2015; 16(8):1220-30. PMC: 4622725. DOI: 10.1080/15384047.2015.1056409. View

17.

Sauter M, Brett E, Muller C, Machens H, Duscher D . Novel Assay Analyzing Tropism between Adipose-Derived Stem Cells and Breast Cancer Cells Reveals a Low Oncogenic Response. Breast Care (Basel). 2019; 14(5):278-287. PMC: 6883470. DOI: 10.1159/000503411. View

18.

Liu Z, Shi A, Song D, Han B, Zhang Z, Ma L . Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. Am J Cancer Res. 2017; 7(3):574-583. PMC: 5385645. View

19.

Nieman K, Romero I, Van Houten B, Lengyel E . Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 2013; 1831(10):1533-41. PMC: 3742583. DOI: 10.1016/j.bbalip.2013.02.010. View

20.

Tacar O, Sriamornsak P, Dass C . Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013; 65(2):157-70. DOI: 10.1111/j.2042-7158.2012.01567.x. View